|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Investigation |
1 Department of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, California; 2 David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; 3 Division of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan; and 4 Heart Center, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan
Correspondence: For correspondence or reprints contact: Serge D. Van Kriekinge, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Ste. A047N, Los Angeles, CA 90048. E-mail: vankriekinges{at}cshs.org
Although many patients with heart failure benefit from cardiac resynchronization therapy (CRT), predicting which patients will respond to CRT remains challenging. Recent evidence suggests that the analysis of mechanical dyssynchrony using gated myocardial perfusion SPECT (MPS) may be an effective tool. The aim of this study was to evaluate global and regional gated MPS dyssynchrony measurements by comparing parameters obtained from patients with a low likelihood (LLk) of conduction abnormalities and coronary artery disease and patients with left bundle branch block (LBBB). Methods: A total of 86 consecutive patients with LLk and 72 consecutive patients with LBBB, all without prior myocardial infarction or sternotomy, were studied using gated MPS. Global (histogram SD [
], bandwidth [β], and entropy [
]) and regional (wall- and segment-based differences of means [
µW and
µS, respectively] or modes [
MW and
MS, respectively]) dyssynchrony measures were calculated by Fourier harmonic phase-angle analysis of local myocardial count variations over the cardiac cycle for each patient, and then unpaired t tests were used to determine which parameters were sex-specific and how well they discriminated between the LLk and LBBB populations. Receiver-operating-characteristic analysis was also performed to calculate the area under the curve (AUC), sensitivity (Ss), specificity (Sp), and optimal threshold (Th). Results: Global parameters were found to be sex-specific, whereas regional differences were sex-independent. All parameters studied showed statistically significant differences between the groups (all global, P < 0.05; all regional, P < 0.0001). Receiver-operating-characteristic analysis yielded higher AUC, Ss, and Sp for
and regional parameters (
: AUC = 0.95/0.96, Ss = 94%/88%, Sp = 89%/91%, and Th = 53.9%/60.6% for women/men;
µW: AUC = 0.93, Ss = 88%, Sp = 86%, and Th = 10.5°;
µS: AUC = 0.94, Ss = 90%, Sp = 94%, and Th = 9.2°;
MW: AUC = 0.95, Ss = 90%, Sp = 94%, and Th = 15°; and
MS: AUC = 0.95, Ss = 88%, Sp = 90%, and Th = 10.5°) than for global parameters (
: AUC = 0.75/0.67, Ss = 81%/66%, Sp = 63%/64%, and Th = 16.5°/22.2° for women/men; β: AUC = 0.80/0.72, Ss = 71%/71%, Sp = 79%/64%, and Th = 69°/81° for women/men). Conclusion: The computed parameters all discriminate effectively between LLk and LBBB populations. Measurements that are less dependent on the shape of the phase-angle distribution histogram provided higher sensitivity and specificity for this purpose. Further study is needed to evaluate these parameters for the purpose of predicting response to CRT.
Key Words: left ventricular dyssynchrony left bundle branch block cardiac resynchronization therapy myocardial perfusion gated SPECT
COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
M. M. Boogers, S. D. Van Kriekinge, M. M. Henneman, C. Ypenburg, R. J. Van Bommel, E. Boersma, P. Dibbets-Schneider, M. P. Stokkel, M. J. Schalij, D. S. Berman, et al. Quantitative Gated SPECT-Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy J. Nucl. Med., May 1, 2009; 50(5): 718 - 725. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |